ACRO Biomedical Co., Ltd. (TPEX:6748)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
AGO Biomedical	38.12M	42.32M	49.44M	27.45M	21.83M
AGO Biomedical Growth	-9.93%	-14.41%	80.13%	25.74%	21.06%
Other	139.00K	1.92M	1.63M	187.00K	-
Other Growth	-92.75%	17.91%	768.98%	-	-
Total	38.26M	44.23M	51.06M	27.63M	21.83M
Total Growth	-13.51%	-13.38%	84.79%	26.59%	21.04%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Taiwan	24.94M	40.44M	25.53M	26.55M	20.21M
Taiwan Growth	-38.33%	58.39%	-3.83%	31.40%	13.63%
Vietnam	12.60M	3.02M	2.24M	-	-
Vietnam Growth	317.81%	34.88%	-	-	-
Other	714.00K	776.00K	849.00K	1.08M	1.62M
Other Growth	-7.99%	-8.60%	-21.68%	-33.21%	546.61%
Australia	-	-	22.45M	-	-
Total	38.26M	44.23M	51.06M	27.63M	21.83M
Total Growth	-13.51%	-13.38%	84.79%	26.59%	21.04%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 9, 2026

Data Sources Report a data error